Holland exits Mauritskliniek in sale to PE-backed Corius


Holland Capital has sold Dutch dermatology platform Mauritskliniek to Ufenau-backed Corius, nine months after an exit to Triton-owned Bergman was blocked by the competition authorities.



Source link

Leave a Reply

Your email address will not be published.